Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-40A is a small intracellular GTPase belonging to the Rab family. It carries a C-terminal SOCS box that suggests it may act as a substrate-recognition component of a SOCS-box E3 ubiquitin ligase complex, mediating ubiquitination and subsequent proteasomal degradation of target proteins. It is implicated in intracellular membrane trafficking, particularly in vesicle biogenesis, transport, and fusion. Mutations or altered expression of RAB40A have been associated with various diseases, including certain cancers and rare syndromes such as Martin-Probst syndrome, but there is currently no evidence for therapeutic targeting or biomarker utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-40A (RAB40A).